“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Health Canada, the Canadian government’s department responsible for national health policy, earlier this month updated the product information label for Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic (also known as BNT162b2 or “Comirnaty” vaccine) to reflect reported cases of Bell’s palsy—an immune mediated neurological disorder characterized by temporary muscle weakness or paralysis on one side of […]
Singapore’s Ministry of Health (MOH) announced on Aug. 16, 2021 that it had awarded S$225,000 (just over $165,000) to the family of a 16-year-old boy in Singapore who suffered a heart attack six days after receiving the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) COVID-19 biologic (also known as BNT162b2 or “Comirnaty” vaccine) on […]
A 22-year-old man in France died on July 26, 2021 nine hours after receiving the first dose of Pfizer/BioNTech’s experimental COVID-19 biologic (also known as BNT162b2 or “Comirnaty” vaccine). Maxime Beltra was vaccinated at about 2 pm in the southern French city of Sète and then went to a local restaurant with friends. At 10 […]
The European Medicines Agency (EMA) announced on Aug. 11, 2021 that it is investigating a possible link between the experimental messenger RNA (mRNA) biologics developed by Pfizer/BioNTech and Moderna/NIAID and an allergic skin condition called erythema multiforme, as well as two kidney disorders known as glomerulonephritis and nephrotic syndrome.1 2 Symptoms of erythema multiforme are […]
Soon after the United States began rolling out experimental COVID-19 vaccines distributed under an Emergency Use Authorization (EUA), doctors began seeing an influx of female patients making mammogram appointments after the women experienced enlarged lymph nodes, known as axillary lymphadenopathy, in the armpit area after receiving a dose of mRNA COVID-19 vaccine.1 Laura Esserman, MD, […]
Worry about the safety of the Johnson & Johnson/Janssen experimental human advenovirus COVID-19 vaccine persists after a ten-day pause on distribution of the vaccine earlier this year.1 Food and Drug Administration (FDA) warnings of heart and neurological issues2 and, most recently, a published study suggesting that the J&J vaccine is far less effective against the […]
With close to one-third of adults in the United States choosing to delay or forego the experimental COVID-19 vaccines, the medical industry is reportedly trying to understand the reasons behind the hesitancy and figure out how to persuade more Americans to get vaccinated.
A recent published medical report out of Mexico details two cases of healthy, female health care workers who got COVID-19 vaccines and, three days later, developed “thyroid hyperactivity, suppressed thyroid-stimulating hormone, and elevated antithyroid antibodies.” They were both diagnosed with vaccine-induced Graves’ disease. According to the authors who wrote up the cases, “autoimmune/inflammatory syndrome induced […]
Opinion | On July 8, 2021, Pfizer, Inc. announced it was developing a booster dose for its experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19. It said that it had observed waning immunity among people who received the standard two-dose regimen of the product. The company said it planned to begin clinical studies of the […]
Last week, the U.S. Centers for Disease Control and Prevention (CDC) released data containing reports of health problems, including deaths, following receipt of federally recommended vaccines that have been filed with the federal Vaccine Adverse Event Reporting System (VAERS).1 2 The latest release of VAERS data included descriptions of 438,441 adverse event reports following COVID-19 […]